₹ 62.3 Cr
Volume transacted
519.2 K
stocks traded
Last Updated time: 18 Sep 9.00 AM
Jubilant Pharmova Ltd
NSE: JUBLPHARMA
YEARHIGH
₹ 1247
Last updated: 18 Sep 24
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
18 Sep 2024 | 1199 | 1203.65 | 1223.9 | 1187.85 |
17 Sep 2024 | 1218.85 | 1214.45 | 1235.2 | 1191.1 |
16 Sep 2024 | 1224.45 | 1192.95 | 1247 | 1166.4 |
13 Sep 2024 | 1193.8 | 1048.7 | 1228.75 | 1032.8 |
12 Sep 2024 | 1048.25 | 1038.3 | 1065.55 | 1024.9 |
11 Sep 2024 | 1031.1 | 1042.7 | 1060.15 | 1012.6 |
10 Sep 2024 | 1017.3 | 1022.95 | 1044.6 | 1010.8 |
09 Sep 2024 | 1030.4 | 955.05 | 1047 | 933.75 |
06 Sep 2024 | 951.9 | 958.55 | 970 | 934 |
05 Sep 2024 | 937.85 | 927.8 | 941.2 | 926.25 |
Date | Price |
---|---|
18 Sep 2024 | 1199 |
17 Sep 2024 | 1218.85 |
16 Sep 2024 | 1224.45 |
13 Sep 2024 | 1193.8 |
12 Sep 2024 | 1048.25 |
11 Sep 2024 | 1031.1 |
10 Sep 2024 | 1017.3 |
09 Sep 2024 | 1030.4 |
06 Sep 2024 | 951.9 |
05 Sep 2024 | 937.85 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Jubilant Pharmova Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Jubilant Pharmova Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA
The United States Food & Drug Administration (USFDA) conducted an audit of the facility fr...
Read more
11 Sep 202410:52
Jubilant Pharmova Ltd leads gainers in 'A' group
Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemica...
Read more
09 Sep 202412:00
Volumes soar at Jubilant Pharmova Ltd counter
Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are amon...
Read more
09 Sep 202414:30
Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories
Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant...
Read more
16 Aug 202418:41
Volumes soar at Jubilant Pharmova Ltd counter
Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Me...
Read more
01 Aug 202414:30
Jubilant Pharmova hits 52-week high after Q1 PAT zooms to Rs 482 cr
Total income increased by 9.41% to Rs 1,745.7 crore in Q1 FY25 as compared with Rs 1,595.5...
Read more
19 Jul 202415:06
FAQs for 52 Week High of Jubilant Pharmova Ltd
What is the significance of Jubilant Pharmova Ltd reaching its 52-week high?
Why do investors monitor Jubilant Pharmova Ltd 52-week high?
Is Jubilant Pharmova Ltd a good buy when it hits its 52-week high?
What should I consider before investing in Jubilant Pharmova Ltd at its 52-week high?
Can Jubilant Pharmova Ltd stock price continue to rise after reaching its 52-week high?
Unlimited trading at just
Rs. 199*